Effect of sacubitril/valsartan on lipid metabolism in patients with chronic kidney disease combined with chronic heart failure: a retrospective study

被引：0
|
作者：
Manzhi Li
Ao Zhong
Yifan Tang
Jinnuo Yu
Mengmeng Wu
Karthick Kumaran Munisamy Selvam
Dong Sun
机构：
[1] Affiliated Hospital of Xuzhou Medical University,Department of Nephrology
[2] Xuzhou Medical University,Department of Internal Medicine and Diagnostic
来源：
Lipids in Health and Disease | / 23卷
关键词：
Sacubitril/valsartan; Lipids; Chronic kidney disease; Chronic heart failure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Renal protection in chronic heart failure: focus on sacubitril/valsartan
    Pontremoli, Roberto
    Borghi, Claudio
    Filardi, Pasquale Perrone
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (05) : 445 - 452
  • [22] The safety of sacubitril-valsartan for the treatment of chronic heart failure
    Tyler, Jeffrey M.
    Teerlink, John R.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (02) : 257 - 263
  • [23] Safety profile of sacubitril-valsartan in heart failure with reduced ejection fraction with chronic kidney disease, a real life study
    Recio Mayoral, A. Alejandro
    Cortes Cortes, F. J.
    Caravaca Perez, P.
    Arroyo Monino, D. F.
    Ribadeneira Ruiz, M.
    Fernandez, I.
    Ruiz Garcia, M. P.
    Chaparro Munoz, M.
    Castro Fernandez, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 231 - 231
  • [24] CLINICAL EFFECTS OF ARNI (SACUBITRIL/ VALSARTAN) IN PATIENTS WITH CHRONIC KIDNEY DISEASE WITH HYPERTENSION
    Kobayashi, Norihiro
    Nakatani, Yoshihisa
    Shimizu, Kazuyuki
    Nakano, Yukihito
    Sakaguchi, Mika
    Arima, Shuji
    JOURNAL OF HYPERTENSION, 2023, 41 : E391 - E392
  • [25] RETRACTED: Clinical Effect of Qili Qiangxin Capsule Combined with Sacubitril-Valsartan in Patients with Chronic Heart Failure (Retracted Article)
    Yao, Jiafang
    Liu, Dan
    JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
  • [26] RETROSPECTIVE STUDY WITH SACUBITRIL-VALSARTAN IN PATIENTS WITH CHRONIC HEART FAILURE FROM REDUCED EJECTION FRACTION REDUCES VENTRICULAR ARRHYTHMIA?
    Cerciello, A.
    Lamaida, N.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0G) : G153 - G153
  • [27] Inferior vena cava diameter in patients with chronic heart failure and chronic kidney disease: a retrospective study
    Li, Jianan
    Wang, Chi
    Dong, Hui wu
    Qi, Jing
    Rao, Chongyou
    Li, Qiuyang
    He, Kunlun
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2025, 30 (01)
  • [28] Sacubitril/valsartan in chronic kidney disease, the nephrologist point of view
    Quiroga, Borja
    de Santos, Antonio
    Sapiencia, David
    Saharaui, Yamila
    Alvarez-Chiva, Vicente
    NEFROLOGIA, 2019, 39 (06): : 646 - 652
  • [29] Effect of Sacubitril/Valsartan on renal function in patients with chronic kidney disease and heart failure with preserved ejection fraction: A real-world 12-week study
    Jia, Ruoyu
    Zhang, Xuejie
    Xu, Yizhou
    Zheng, Zhifang
    Jiang, Luhua
    Zhang, Xin
    Sun, Chen
    Wu, Xin
    Li, Shulin
    Raj, Ashok
    Sun, Dong
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 928
  • [30] Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study
    Nougue, Helene
    Pezel, Theo
    Picard, Francois
    Sadoune, Malha
    Arrigo, Mattia
    Beauvais, Florence
    Launay, Jean-Marie
    Cohen-Solal, Alain
    Vodovar, Nicolas
    Logeart, Damien
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (05) : 598 - 605
12345